Case for Quality Voluntary Improvement Program (also known as the Medical Device Discovery Appraisal Program) white paper

The CMMI Institute has published the FDA written white paper that describes the state of the MDDAP pilot program through September of 2019. Read / download it here:

MDDAP looks to develop variation for “struggling sites”

“That’s why the FDA is collaborating with the MDIC and Pittsburgh, PA-based CMMI Institute to develop a variation of the VIP program for struggling sites” — read more in the latest Medtech Insight article about the collaboration between FDA CDRH, the CMMI Institute, MDIC, Medical device manufacturers and appraisers in the Case for Quality Voluntary … More MDDAP looks to develop variation for “struggling sites”